
Gwaro iri rakazara rinoongorora kufambira mberi kwazvino mukurapwa kwegomarara remapapu kusiri diki (NSCLC) kunowanikwa kuChina, tichitarisa zvipatara zvinotungamira zvine matekinoroji ekucheka-cheka uye nyanzvi dzekurapa vane ruzivo. Tichaongorora nzira dzakasiyana-siyana dzekurapa, kusanganisira kurapa kwakanangwa, immunotherapy, chemotherapy, uye kuvhiyiwa, tichiratidza zvakakosha zvevarwere vari kutsvaga kurapwa kwakanyanya.
Isiri diki-diki kenza yemapapu inoverengera inosvika 85% yezvese kenza yemapapu inoongororwa. Iboka rakasiyana-siyana regomarara rine maitiro akasiyana uye mhinduro pakurapa. Kukurumidza kuongororwa uye kusarudzwa kwakakodzera kwekurapa kwakakosha pakuvandudza mhedzisiro yevarwere. Kunzwisisa iyo chaiyo mhando uye nhanho yeNSCLC yakakosha usati waona iyo yakakwana chirongwa chekurapa.
Nhanho yeNSCLC inokanganisa zvakanyanya nzira dzekurapa. Yekutanga-nhanho NSCLC inogona kusanganisira kuvhiyiwa, nepo nhanho dzepamberi dzinowanzoda musanganiswa wechemotherapy, kurapa kwakanangwa, uye immunotherapy. Kusarudzwa kwechirongwa chekurapa kwakasarudzika uye kunotsanangurwa nezvinhu zvakaita sehutano hwemurwere hwese, iyo chaiyo mhando yeNSCLC, uye kuvapo kwechero metastases. The China itsva isiri-diki yesero yemapapu inorapa zvipatara kupa nzira dzakasiyana-siyana dzakanangana nezvinodiwa nemurwere wega wega.
Mishonga yakanangwa inotarisa pane chaiyo genetic mutations kana mapuroteni anofambisa kukura kwekenza maseru. Mishonga iyi inogona kunyatsoshanda kune varwere vane chaiyo NSCLC subtypes, sevaya vane EGFR kana ALK mutations. Vazhinji vachitungamira China itsva isiri-diki yesero yemapapu inorapa zvipatara kupa mukana kune ichangoburwa yakanangwa marapirwo.
Immunotherapy inoshandisa simba rekudzivirira kwemuviri kurwisa cancer. Checkpoints inhibitors, rudzi rwe immunotherapy, vari kushandura kurapwa kweNSCLC, kunyanya mumatanho epamusoro. Mishonga iyi inoshanda nekuvhara mapuroteni anodzivirira immune system kurwisa masero egomarara. Zvakawanda China itsva isiri-diki yesero yemapapu inorapa zvipatara vari pamberi pekutsvagisa immunotherapy uye kushandisa.
Chemotherapy inoramba iri dombo repakona rekurapa kweNSCLC, inowanzo shandiswa pamwe chete nemamwe marapirwo seanonangwa kurapa kana immunotherapy. Iyo chaiyo chemotherapy regimen inoenderana nedanho rekenza uye hutano hwemurwere hwese. Zvipatara muChina zvinopa advanced China itsva isiri-diki yesero yemapapu inorapa zvipatara batanidza chemotherapy zvine hungwaru muzvirongwa zvekurapa zvakakwana.
Kuvhiya resection inogona kuve sarudzo kune varwere vane nhanho yekutanga, inoshanda NSCLC. Minimally invasive nzira dzekuvhiya, dzakadai sevhidhiyo-inobatsira thoracoscopic kuvhiyiwa (VATS), iri kuwedzera kushandiswa kuderedza kushungurudzika nekuvandudza nguva dzekupora. Unyanzvi hwepamusoro hwekuvhiya hunowanikwa kune vakawanda vanotungamira China itsva isiri-diki yesero yemapapu inorapa zvipatara.
Kusarudza chipatara chakakodzera chako China itsva isiri-diki yekenza yemapapu kurapwa zvinoda kunyatsofungwa. Zvinhu zvekufunga nezvazvo zvinosanganisira hunyanzvi hwechipatara mukurapa kweNSCLC, kuwana matekinoroji epamusoro, uye ruzivo rwechikwata chekurapa. Tsvagiridzo yakakwana uye kubvunzana nevashandi vehutano zvakakosha pakuita sarudzo ine ruzivo.
Zvipatara zvakati wandei muChina zvinozivikanwa nekunaka kwazvo muoncology uye hunyanzvi hwavo mukurapa NSCLC. Zvipatara izvi zvinowanzo shanda pamwe nemasangano epasi rose ekutsvagisa uye zvinopa mukana wekuwana miedzo yekiriniki uye kufambira mberi kwazvino. Kuti uwane runyoro rwakadzama uye ruzivo pane yavo chaiyo hunyanzvi, tinokukurudzira kuti utarise ane mukurumbira madhairekitori ekurapa uye zviwanikwa zvepamhepo. Imwe sangano rakadaro rine tarisiro yakasimba pakutsvaga kenza ndeye Shandong Baofa Cancer Research Institute.
Ruzivo urwu rwakaitirwa zvinangwa zvekudzidzisa chete uye harufanirwe kutorwa sezano rekurapa. Gara uchitaurirana nemutarisiri wako wehutano kuti uongororwe uye mazano ekurapwa.
parutivi>
body>